We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Arcera and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.
Necessary Cookies Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics Cookies
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
Latest News
Stay up-to-date with Arcera’s most recent updates.
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug...
Tuesday 10th June 2025
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...
Achieving Level 1 B-BBEE status in South Africa for the sixth year...
Wednesday 21st May 2025
For the sixth consecutive year, Acino has achieved Level 1 Broad-Based Black Economic Empowerment (B-BBEE) contributor status in South Africa.
Leadership Announcements and New Arcera Structure
Monday 2nd December 2024
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
Acino signs an exclusive agreement with LG Chem for Novel Treatments for...
Wednesday 24th July 2024
Acino will market, commercialize, and distribute Hyruan One® in Brazil, and Zemiglo® and Zemimet® SR (Zemiduo® SR in Mexico) in...
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s...
Monday 24th June 2024
ADQ launches holding company Arcera to build a global life sciences powerhouse...
Monday 1st April 2024
Abu Dhabi, UAE – 01/04/2024: ADQ, an Abu Dhabi-based investment and holding company, has announced the formation of Arcera, a...
Acquisition of M8 Pharmaceuticals and integration into Acino
Monday 4th December 2023
With nearly 300 new employees on board, Acino will enhance its presence in Latin America and strengthen its business through...
ADQ to acquire leading Turkish pharmaceuticals company Birgi Mefar Group
Monday 13th June 2022
ADQ to acquire leading Turkish Pharmaceutical Contract Development and Manufacturing Organization (CDMO) of sterile solutions and injectables.
ADQ further strengthens its Healthcare & Pharma portfolio with agreement to acquire...
Thursday 16th September 2021
ADQ to acquire Acino, a Swiss-based pharmaceutical manufacturer with presence in more than 90 countries.
ADQ plans to bolster its healthcare and pharma portfolio by acquiring Amoun...
Wednesday 31st March 2021
ADQ to acquire Amoun, one of Egypt’s leading pharmaceutical and life sciences companies.
Media contacts
Do you need to get in touch with us?
For media enquiries, contact our Global Communications team.
